83 related articles for article (PubMed ID: 2166466)
21. Nucleosides. 129. Synthesis of antiviral nucleosides: 5-alkenyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracils.
Watanabe KA; Su TL; Reichman U; Greenberg N; Lopez C; Fox JJ
J Med Chem; 1984 Jan; 27(1):91-4. PubMed ID: 6317862
[TBL] [Abstract][Full Text] [Related]
22. Acyclovir in the treatment of simian varicella virus infection of the African green monkey.
Soike KF; Gerone PJ
Am J Med; 1982 Jul; 73(1A):112-7. PubMed ID: 6285700
[TBL] [Abstract][Full Text] [Related]
23. Drug susceptibilities of isolates of varicella-zoster virus in a clinical study of oral brovavir.
Machida H; Nishitani M
Microbiol Immunol; 1990; 34(4):407-11. PubMed ID: 2163486
[TBL] [Abstract][Full Text] [Related]
24. Strains of varicella-zoster virus resistant to 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
Sakuma T
Antimicrob Agents Chemother; 1984 Jun; 25(6):742-6. PubMed ID: 6331298
[TBL] [Abstract][Full Text] [Related]
25. Structures of metabolites isolated from urine of mice treated with the antiviral agent, 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-methyluracil.
Feinberg A; Vidal PM; Fox JJ; Watanabe KA; Chun MW; Field FH; Bencsath A; Chait B; Philips FS
Drug Metab Dispos; 1984; 12(6):784-6. PubMed ID: 6150831
[No Abstract] [Full Text] [Related]
26. Antiviral activity of FIAU (1-[2'deoxy-2'-fluoro-1-beta-D-arabinofuranosyl]-5-iodo-uridine) on strains of cytomegalovirus sensitive and resistant to ganciclovir.
Drew WL; Miner R; King D
J Infect Dis; 1991 Jun; 163(6):1388-9. PubMed ID: 1645389
[No Abstract] [Full Text] [Related]
27. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H
Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386
[TBL] [Abstract][Full Text] [Related]
28. A proposed mechanism for the selective inhibition of human cytomegalovirus replication by 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-fluorouracil.
Suzuki S; Misra HK; Wiebe LI; Knaus EE; Tyrrell DL
Mol Pharmacol; 1987 Mar; 31(3):301-6. PubMed ID: 3031445
[TBL] [Abstract][Full Text] [Related]
29. 18F-FEAU as a radiotracer for herpes simplex virus thymidine kinase gene expression: in-vitro comparison with other PET tracers.
Buursma AR; Rutgers V; Hospers GA; Mulder NH; Vaalburg W; de Vries EF
Nucl Med Commun; 2006 Jan; 27(1):25-30. PubMed ID: 16340720
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and antiviral activity in simian varicella virus-infected monkeys of (R,S)-9-[4-hydroxy-2-(hydroxymethyl) butyl]guanine, an anti-varicella-zoster virus drug.
Lake-Bakaar DM; Abele G; Lindborg B; Soike KF; Datema R
Antimicrob Agents Chemother; 1988 Dec; 32(12):1807-12. PubMed ID: 2854453
[TBL] [Abstract][Full Text] [Related]
31. In vivo antiviral activity of recombinant type alpha interferon A in monkeys with infections due to simian varicella virus.
Soike KF; Kramer MJ; Gerone PJ
J Infect Dis; 1983 May; 147(5):933-8. PubMed ID: 6842026
[TBL] [Abstract][Full Text] [Related]
32. Imaging of HSV-tk Reporter gene expression: comparison between [18F]FEAU, [18F]FFEAU, and other imaging probes.
Miyagawa T; Gogiberidze G; Serganova I; Cai S; Balatoni JA; Thaler HT; Ageyeva L; Pillarsetty N; Finn RD; Blasberg RG
J Nucl Med; 2008 Apr; 49(4):637-48. PubMed ID: 18344433
[TBL] [Abstract][Full Text] [Related]
33. Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-beta-D- arabinofuranosyl)thymine and 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5- iodocytosine.
Philips FS; Feinberg A; Chou TC; Vidal PM; Su TL; Watanabe KA; Fox JJ
Cancer Res; 1983 Aug; 43(8):3619-27. PubMed ID: 6305489
[No Abstract] [Full Text] [Related]
34. Efficacy of (-)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine in African green monkeys infected with simian varicella virus.
Soike KF; Bohm R; Huang JL; Oberg B
Antimicrob Agents Chemother; 1993 Jun; 37(6):1370-2. PubMed ID: 8392312
[TBL] [Abstract][Full Text] [Related]
35. Antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against thymidine kinase negative strains of varicella-zoster virus.
Kawai H; Yoshida I; Suzutani T
Microbiol Immunol; 1993; 37(11):877-82. PubMed ID: 8295566
[TBL] [Abstract][Full Text] [Related]
36. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
[TBL] [Abstract][Full Text] [Related]
37. Effect of acyclovir on the uptake of 131I-labelled 1-(2'fluoro-2'-deoxy-beta-D-arabinofuranosyl)-5-iodouracil in herpes infected cells.
Tovell DR; Yacyshyn HP; Misra HK; Knaus EE; Wiebe LI; Samuel J; Gill MJ; Tyrrell DL
J Med Virol; 1987 Jun; 22(2):183-8. PubMed ID: 3039053
[TBL] [Abstract][Full Text] [Related]
38. Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU).
Fanucchi MP; Leyland-Jones B; Young CW; Burchenal JH; Watanabe KA; Fox JJ
Cancer Treat Rep; 1985 Jan; 69(1):55-9. PubMed ID: 2981621
[TBL] [Abstract][Full Text] [Related]
39. Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogs.
Najjar AM; Nishii R; Maxwell DS; Volgin A; Mukhopadhyay U; Bornmann WG; Tong W; Alauddin M; Gelovani JG
J Nucl Med; 2009 Mar; 50(3):409-16. PubMed ID: 19223410
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of simian varicella virus infection in African green monkeys by recombinant human tumor necrosis factor alpha.
Soike KF; Czarniecki CW; Baskin G; Blanchard J; Liggitt D
J Infect Dis; 1989 Feb; 159(2):331-5. PubMed ID: 2536783
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
